InvestorsHub Logo
Followers 13
Posts 731
Boards Moderated 0
Alias Born 07/12/2005

Re: Tekterra post# 5164

Friday, 08/18/2017 6:08:07 PM

Friday, August 18, 2017 6:08:07 PM

Post# of 7747
Never seen a RS on any company be a good thing.

If Nantcell is in on it they are foolish,

If anything, since the product/s is/are real and the global license deal is evident both companies should merge an a profitable agreement reached without share splits.

Paper holds every word you put on it,

An RS is like cheating, the company will not be trusted again.

RS "NO"

6 month daily chart, forth run of the year coming up. Hold your shares.

http://www.fiercebiotech.com/biotech/soon-shiong-s-nantcell-356m-deal-for-underperforming-cytrx-cancer-drug

Mr Soon is beru smart and has a ton of money, they will be loading up next week,

This is a strategic plan to acquire cheap shares.

Wise